| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 300 |
| 1 | EPTINEZUMAB-JJMR | 133 |
| 2 | PREDNISONE | 105 |
| 3 | DUPILUMAB | 102 |
| 4 | METHOTREXATE SODIUM | 97 |
| 5 | METHOTREXATE | 95 |
| 6 | INSULIN LISPRO | 81 |
| 7 | ACETAMINOPHEN | 61 |
| 8 | SECUKINUMAB | 55 |
| 9 | TADALAFIL | 53 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPTINEZUMAB-JJMR | 133 | 0.0136 |
| 1 | INSULIN LISPRO-AABC | 20 | 0.0095 |
| 2 | ALFUZOSIN HYDROCHLORIDE | 19 | 0.0077 |
| 3 | AMIFAMPRIDINE PHOSPHATE | 17 | 0.0057 |
| 4 | INFLIXIMAB-DYYB | 14 | 0.0041 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 32 | 0.0038 |
| 6 | DUTASTERIDE | 30 | 0.0036 |
| 7 | DAPTOMYCIN | 30 | 0.0032 |
| 8 | PYRIDOSTIGMINE BROMIDE | 15 | 0.0020 |
| 9 | UBROGEPANT | 11 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 375 |
| 1 | Corticosteroid [EPC] | 176 |
| 2 | Calcitonin Gene-related Peptide Antagonist [EPC] | 133 |
| 3 | Insulin Analog [EPC] | 126 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 123 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 102 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 96 |
| 7 | Benzodiazepine [EPC] | 91 |
| 8 | Proton Pump Inhibitor [EPC] | 69 |
| 9 | Interleukin-17A Antagonist [EPC] | 61 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Calcitonin Gene-related Peptide Antagonist [EPC] | 133 | 0.0136 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 21 | 0.0101 |
| 2 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 3 | Interferon alfa-2b [EPC] | 6 | 0.0032 |
| 4 | Lipopeptide Antibacterial [EPC] | 30 | 0.0032 |
| 5 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 14 | 0.0020 |
| 7 | Macrolide Antibacterial [EPC] | 2 | 0.0020 |
| 8 | Provitamin D2 Compound [EPC] | 49 | 0.0016 |
| 9 | Interleukin-17A Antagonist [EPC] | 61 | 0.0016 |